Risk of Cervical Cancer Following Incident, Persistent and History-unknown HPV Detection
Risk of Cervical Cancer Following Incident, Persistent and History-unknown Human Papillomavirus (HPV) Detection by HPV Genotype
The goal of this register-based retrospective observational study is to understand the risk of cervical cancer following incident, persistent and history-unknown HPV detection by HPV genotype in healthy women participating in HPV-based cervical screening. The main questions it aims to answer are:
- Whether an incident HPV detection with certain HPV genotypes has low risk of cervical cancer in 3 to 5 years thus does not need further clinical assessment before the next screening test?
- How risky a persistent HPV detection is, and whether persistent detection of any high-risk HPV genotype warrant immediate clinical assessment?
- How risky a HPV detection is, if no previous HPV test result is available?
As being a register-based retrospective observational study, study subjects will not be asked to do any specific task for this study.
研究概览
详细说明
This study includes all women in the study population (women at screening ages and living in the Stockholm region during 2014-2023) who had HPV positive test result(s) in the primary HPV screening. In 2014-2016, half of the screening population were randomised to primary HPV screening and the other half received cytology-based screening (NCT01511328). From 2017 onwards, all women received primary HPV screening. As data are retrieved from established registries which are already accessible to the researchers for previous and ongoing related research projects, the data collection time is almost negligible.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Jiangrong Wang, PhD
- 电话号码:+46769309451
- 邮箱:jiangrong.wang@ki.se
研究联系人备份
- 姓名:Joakim Dillner, PhD
- 邮箱:joakim.dillner@ki.se
学习地点
-
-
-
Stockholm、瑞典、141 52
- 招聘中
- Centre for Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, Karolinska Institutet
-
接触:
- Jiangrong Wang, PhD
- 电话号码:+46769309451
- 邮箱:jiangrong.wang@ki.se
-
接触:
-
副研究员:
- Jiangrong Wang, PhD
-
首席研究员:
- Joakim Dillner, PhD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Women living in the Great Stockholm Region in Sweden, at cervical screening ages (age 22-70 years), and having had an HPV positive result in the primary HPV test during 2014-2023
描述
Inclusion Criteria:
- Women living in the Great Stockholm Region in Sweden, at cervical screening ages (age 22-70 years), and having had an HPV positive result in primary HPV test during 2014-2023
Exclusion Criteria:
- Women without valid personal identity number in the population registry
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:RETROSPECTIVE
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Incident HPV detection
The first HPV positive result in the primary HPV test, following an HPV negative test result in the previous primary HPV test |
All data will be retrieved retrospectively from registry data. |
|
Persistent HPV detection
The HPV positive result in the primary HPV test following an HPV positive test result with the same genotype in the previous primary HPV test |
All data will be retrieved retrospectively from registry data. |
|
History-unknown HPV detection
The first HPV positive result in the primary HPV test, without any primary HPV test record in the past |
All data will be retrieved retrospectively from registry data. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Diagnosis of invasive cervical cancer
大体时间:From HPV infection to the end of the study Dec 31st, 2024
|
Primary and invasive cervical cancer |
From HPV infection to the end of the study Dec 31st, 2024
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Precancerous lesion CIN2+ (Cervical Intraepithelial Neoplasia grade 2 and above)
大体时间:From HPV infection to the end of the study Dec 31st, 2024
|
CIN2, CIN3, Adenocarcinoma in situ |
From HPV infection to the end of the study Dec 31st, 2024
|
合作者和调查者
出版物和有用的链接
一般刊物
- Bjorge T, Stoer NC, Hverven SK, Nygard M, Trope A, Engesaeter B. Risk of high-grade cervical lesions in the second round of primary human papillomavirus testing in CervicalScreen Norway: A population-based cohort study. Int J Cancer. 2025 Jul 15;157(2):251-259. doi: 10.1002/ijc.35359. Epub 2025 Feb 8.
- Wei F, Georges D, Man I, Baussano I, Clifford GM. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet. 2024 Aug 3;404(10451):435-444. doi: 10.1016/S0140-6736(24)01097-3.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- IPUHPV&CxCa
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
IPD will be derived from the Swedish National Cervical Screening Registry and the Swedish National Quality Register for Gynaecological Cancers. Data from these two registries can be shared upon application, provided that ethical approval is obtained.
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.